nbi 27914 has been researched along with lauric acid in 1 studies
Studies (nbi 27914) | Trials (nbi 27914) | Recent Studies (post-2010) (nbi 27914) | Studies (lauric acid) | Trials (lauric acid) | Recent Studies (post-2010) (lauric acid) |
---|---|---|---|---|---|
76 | 0 | 29 | 921 | 38 | 343 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Fu, H; Guan, X; Gui, B; Guo, Y; Hu, J; Jin, L; Li, S; Wang, J; Xu, Y; Zhang, Q; Zhang, R | 1 |
1 other study(ies) available for nbi 27914 and lauric acid
Article | Year |
---|---|
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
Topics: Aniline Compounds; Animals; Arteritis; Blood Coagulation; Corticotropin-Releasing Hormone; Cyclooxygenase 2; Dinoprostone; Intercellular Adhesion Molecule-1; Lauric Acids; Male; Peptide Fragments; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Thromboangiitis Obliterans; Thromboxane B2; Urocortins | 2009 |